Cytosorbents Corporation CTSO
5.34 USD -0.46 (-7.93%)
At closeNov 11, 2026, 4:00 PM EST
5.34 0.00 0.00%
After hours · Nov 11, 4:00 PM ET
5.34 Day range 5.93
2.84 52-week range 17.00
- YTD
- -58.22%
- 1 year
- -61.75%
News
prnewswire.com CytoSorbents to Participate at the 2026 Jefferies Global Healthcare Conference in London PRINCETON, N.J., Nov. 9, 2026 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using…
benzinga.com 12 Health Care Stocks Moving In Friday's After-Market Session Gainers Pomdoctor (NASDAQ:POM) shares rose 25.6% to $1.47 during Friday's after-market session. The market value of their outstanding shares is at $8.3 million. GeneDx Holdings (NASDAQ:WGS) shares…
benzinga.com WBB Securities Initiates Coverage On CytoSorbents with Speculative Buy Rating, Announces Price Target of $9.5 WBB Securities analyst Karen Sterling initiates coverage on CytoSorbents (NASDAQ:CTSO) with a Speculative Buy rating and announces Price Target of $9.5.
benzinga.com 12 Health Care Stocks Moving In Wednesday's Pre-Market Session Gainers Pharvaris (NASDAQ:PHVS) stock moved upwards by 19.4% to $36.9 during Wednesday's pre-market session. The market value of their outstanding shares is at $2.0 billion. CalciMedica (NASDAQ:CALC)…- benzinga.com 12 Health Care Stocks Moving In Monday's Intraday Session Gainers Silence Therapeutics (NASDAQ:SLN) stock increased by 125.6% to $19.59 during Monday's regular session. The market value of their outstanding shares is at $581.1 million. SCWorx (NASDAQ:WORX)…
- benzinga.com 12 Health Care Stocks Moving In Friday's Intraday Session Gainers Marker Therapeutics (NASDAQ:MRKR) stock increased by 21.2% to $1.11 during Friday's regular session. The market value of their outstanding shares is at $14.8 million. Alaunos Therapeutics…